Other OpenAI introduces GPT-Rosalind, its drug discovery AI PharmaphorumIn this week's second AI model launch for life sciences research, OpenAI has introduced GPT-Rosalind, named after UK scientist Rosalind Franklin.OtherRead full story pharminent April 17, 2026 (Last updated: April 17, 2026) Pharmaphorum In this week’s second AI model launch for life sciences research, OpenAI has introduced GPT-Rosalind, named after UK scientist Rosalind Franklin. OtherRead full story Post navigation Previous: Novo may have muscle advantage over Lilly in weight-loss race: preprintNext: RFK Jr. defends Makary, claims pharma ‘owns’ Congress and media Related Stories Other ‘Seismic shift’ as obesity overtakes cancer for R&D returns pharminent May 5, 2026 Other 223: An Interview With Dr. Antn Blatnik on the Molecular Mechanisms Driving Neuromuscular Disease pharminent May 4, 2026 Other FDA tests out ‘real-time’ clinical trials; AbbVie closes in on a KRAS biotech pharminent April 29, 2026
